NHS Business Services Authority (NHSBSA) has released its latest Medicines Used in Mental Health (England) report, now including new data from April to June 2023.

NHS Business Services Authority (NHSBSA) has come 64th out of 100, in the Inspiring Workplaces Awards first-ever global rankings.

NHS Business Service Authority's (NHSBSA) 'Dependency Forming Medicines - England 2015/16 to 2022/23' report shows that in 2022/23, the cost of prescribed dependency forming medicines was £380 million. This was a 51% decrease from 2015/16 when the cost was £780 million.

NHS Business Services Authority’s (NHSBSA) ‘Prescribing for Diabetes 2015/16 to 2022/23’ statistical report shows that in 2022/23, there were 66 million drug items used in treating diabetes prescribed in England for a cost of £1.53 billion, 15% of the total spend on all prescription items prescribed in England.

The NHS Business Services Authority (NHSBSA) has appointed Libby Pink as the organisation’s new Chief Portfolio Officer.